Evidence map›Paper›PMID 26041874›Full record

ArticleThe Journal of general virology2015

Arterivirus nsp12 versus the coronavirus nsp16 2'-O-methyltransferase: comparison of the C-terminal cleavage products of two nidovirus pp1ab polyproteins.

Kathleen C Lehmann, Lisa Hooghiemstra, Anastasia Gulyaeva, Dmitry V Samborskiy, Jessika C Zevenhoven-Dobbe, Eric J Snijder, Alexander E Gorbalenya, Clara C Posthuma

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of general virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Classification, replication, and transcription ofFrontiers in microbiology · 2023
    Review
  6. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.Biochemical Society transactions · 2021
    Review
  7. Article
  8. A nidovirus perspective on SARS-CoV-2.Biochemical and biophysical research communications · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kathleen C LehmannDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Lisa HooghiemstraDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Anastasia GulyaevaDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Dmitry V SamborskiyBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119899 Moscow, Russia.
Jessika C Zevenhoven-DobbeDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Eric J SnijderDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Alexander E GorbalenyaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119899 Moscow, Russia.
Clara C PosthumaDepartment of Medical Microbiology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Leiden University Medical Center · NLLomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 3'-terminal domain of the most conserved ORF1b in three of the four families of the order Nidovirales (except for the family Arteriviridae) encodes a (putative) 2'-O-methyltransferase (2'-O-MTase), known as non structural protein (nsp) 16 in the family Coronaviridae and implicated in methylation of the 5' cap structure of nidoviral mRNAs. As with coronavirus transcripts, arterivirus mRNAs are assumed to possess a 5' cap although no candidate MTases have been identified thus far. To address this knowledge gap, we analysed the uncharacterized nsp12 of arteriviruses, which occupies the ORF1b position equivalent to that of the nidovirus 2'-O-MTase (coronavirus nsp16). In our in-depth bioinformatics analysis of nsp12, the protein was confirmed to be family specific whilst having diverged much further than other nidovirus ORF1b-encoded proteins, including those of the family Coronaviridae. Only one invariant and several partially conserved, predominantly aromatic residues were identified in nsp12, which may adopt a structure with alternating α-helices and β-strands, an organization also found in known MTases. However, no statistically significant similarity was found between nsp12 and the twofold larger coronavirus nsp16, nor could we detect MTase activity in biochemical assays using recombinant equine arteritis virus (EAV) nsp12. Our further analysis established that this subunit is essential for replication of this prototypic arterivirus. Using reverse genetics, we assessed the impact of 25 substitutions at 14 positions, yielding virus phenotypes ranging from WT-like to non-viable. Notably, replacement of the invariant phenylalanine 109 with tyrosine was lethal. We concluded that nsp12 plays an essential role during EAV replication, possibly by acting as a co-factor for another enzyme.

Indexed as

Amino Acid SequenceArchaeal ProteinsArterivirusCoronavirusEquartevirusMethylationMethyltransferasesMolecular Sequence DataOpen Reading FramesPolyproteinsProtein Processing, Post-TranslationalRNA, ViralSequence AlignmentViral Nonstructural ProteinsArchaeal Proteinsmethylcobalamin-coenzyme M methyltransferaseMethyltransferasesPolyproteinsRNA, ViralViral Nonstructural Proteins

Identifiers

PMID26041874
PMCPMC7081073
OpenAlexW2172242120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.